Acute lymphocytic leukemia (ALL)
Showing 1 - 25 of >10,000
Relapsed Childhood ALL, Relapsed Childhood Lymphoblastic Lymphoma Trial in Dallas (Venetoclax, Navitoclax)
Available
- Relapsed Childhood ALL
- Relapsed Childhood Lymphoblastic Lymphoma
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Feb 28, 2022
Drug Induced Neuropathy in Children With ALL
Recruiting
- Acute Lymphocytic Leukemia
-
Trieste, Friuli Venezia Giulia, ItalyIRCCS materno infantile Burlo Garofolo
Mar 31, 2023
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)
Terminated
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Boston, Massachusetts
- +5 more
Jun 11, 2021
ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)
Not yet recruiting
- ALL, Childhood B-Cell
- +2 more
- Tafasitamab
- (no location specified)
Nov 25, 2022
Leukemia Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- cyclophosphamide
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))
Not yet recruiting
- Lymphoma Leukemia
- allogeneic CAR19 regulatory T cells (CAR19-tTreg)
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Dec 6, 2022
Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- CD19 specific Chimeric Antigen Receptor T Cell
-
Columbus, OhioNationwide Children's Hospital
Mar 9, 2023
Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)
Available
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- (no location specified)
Mar 28, 2022
Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)
Recruiting
- Leukemia, Acute Lymphocytic
-
Durham, North CarolinaDuke Cancer Center
Jun 28, 2022
Venetoclax Tablets Crushed and Dissolved Into a Solution
Not yet recruiting
- Hematologic Malignancy
- +18 more
- 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 8, 2023
Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome Trial in Morgantown (umbilical
Completed
- Chronic Myelogenous Leukemia (CML)
- +8 more
- umbilical cord blood (UCB)
-
Morgantown, West VirginiaWest Virginia University Hospitals Mary Babb Randolph Cancer Cen
Jun 7, 2021
Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,
Recruiting
- Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
-
Duarte, California
- +12 more
Jan 4, 2023
Acute Lymphocytic Leukemia Trial (Inotuzumab ozogamicin)
Not yet recruiting
- Acute Lymphocytic Leukemia
- Inotuzumab ozogamicin
- (no location specified)
Jul 11, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
- etoposide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 19, 2022
B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)
Recruiting
- B-Cell Leukemia
- B Cell Lymphoma
- anti-CD19 UCAR-T injection
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Apr 21, 2022
Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,
Active, not recruiting
- Acute Lymphoid Leukemia (ALL)
- +5 more
- Hyperfractionated total body irradiation
- +9 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)
Recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Houston, Texas
- +5 more
May 31, 2022
Acute Lymphocytic Leukemia, Adult B-Cell, BCR-ABL1 Fusion Protein Expression Trial in Nanjing (Flumatinib)
Recruiting
- Acute Lymphocytic Leukemia, Adult B-Cell
- BCR-ABL1 Fusion Protein Expression
-
Nanjing, Jiangsu, China
- +1 more
Mar 22, 2022
Acute T-Lymphocytic Leukemia Trial in Suzhou (Venetoclax combined with azacitidine regimen)
Recruiting
- Acute T-Lymphocytic Leukemia
- Venetoclax combined with azacitidine regimen
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Nov 25, 2021
B Cell Leukemias, B Cell Lymphomas Trial in Philadelphia (CART22 cells transduced with a lentiviral vector to express anti-CD22
Recruiting
- B Cell Leukemias
- B Cell Lymphomas
- CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jan 19, 2022
B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)
Recruiting
- B-cell Acute Lymphocytic Leukemia
- CD19 CAR-T cells
-
Suzhou, ChinaThe First Affiliated Hospital of Soochow University
Jan 11, 2023
Leukemia, Lymphoma Trial in Houston (Actonel (Risedronate), Calcium, Vitamin D)
Completed
- Leukemia
- Lymphoma
- Actonel (Risedronate)
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 2, 2020
Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma Trial in United States (Palbociclib, Cytarabine, Methotrexate)
Active, not recruiting
- Leukemia, Lymphocytic
- +5 more
- Palbociclib
- +8 more
-
Birmingham, Alabama
- +18 more
Feb 25, 2022
BESPONSA Injection 1 mg Special Investigation
Active, not recruiting
- Acute Lymphocytic Leukemia
-
Tokyo, JapanPfizer
Jun 20, 2023